Non-specific molecular targets

"Non-specific molecular targets" is not the name of a defined molecular entity such as a receptor, enzyme, ion channel, or transporter. This term is used to describe any molecular entity that is affected by a substance without a high degree of selectivity or specificity. In pharmacology and drug discovery, non-specific targets refer to molecules where drug or ligand binding is not tightly confined to a single structure or family but may affect a broader array of unrelated molecules, leading to non-selective outcomes. This lack of specificity can result in a greater risk of adverse or off-target effects and is generally considered undesirable in modern drug development, where high specificity is sought to reduce unwanted actions and toxicity[1][2][4][9]. Modern biomedical research and drug development prioritize *specific* molecular targets due to their ability to produce controlled and predictable biological effects. Non-specific targeting is associated with older generations of drugs (e.g., some chemotherapeutics or general anesthetics) that act on various systems simultaneously, often resulting in significant side effects. Thus, "Non-specific molecular targets" should not be used as a canonical biomedical target, and any scientific entry with this designation likely reflects incomplete, ambiguous, or incorrect curation of molecular target data[1][2][9].

Other names

Non-specific targetsBroad-spectrum molecular targetsNon-selective molecular targets